USSTOCK.TODAY
Regular Market
Log in Sign up
Company overview

What Does P3 Health Partners (PIII) Do? – Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Roundup

Updated August 9, 2026 · First published April 23, 2026

P3 Health Partners (PIII) is a physician-led population health management company whose revenue hinges on coordinating care for seniors and operating risk-sharing contracts. Membership growth and medical-cost management drive both earnings and share-price performance, and investors should also weigh the volatility typical of a micro-cap name.

Briefs · earnings · signals, first Subscribe

🏢 What kind of company is P3 Health Partners?

P3 Health Partners is a US population health management company that positions itself as patient-centered and physician-led. It partners with local primary-care physician groups and coordinates preventive care and chronic-disease management for senior patients.

The core business is medical management built on risk-sharing contracts. The company receives per-member fixed payments from insurers, coordinates care, and keeps the difference when actual medical costs fall below those payments — pursuing a value-based-care model within the healthcare facilities industry.

How does P3 Health Partners make money?
Business SegmentRevenue ShareDescription
Risk-Sharing Management ContractsCoreCare coordination revenue based on per-member fixed payments
Physician Network ServicesDiversification PillarOperational and data support for affiliated practices

The bulk of revenue is generated by risk-sharing contracts that pay a fixed per-member amount, so membership growth flows directly into top-line expansion. However, if actual medical costs exceed the payments, margins deteriorate quickly — meaning profitability is highly dependent on member mix and utilization rates. Recently, the emphasis has shifted from aggressive top-line growth toward contract selectivity and cost discipline, with physician network support and geographic expansion serving as complementary pillars.

📐 P3 Health Partners Market Cap and Company Size

Market capitalization stands at $61.1M, and the employee count has not been disclosed.

By market-cap standards, this is a micro-cap healthcare facilities company, and the valuation the market assigns is low relative to its revenue scale. It sits in the small-cap healthcare services peer group alongside DCGO, AUNA, and PARK, and the current phase prioritizes business stabilization and liquidity over capital returns.

📈 P3 Health Partners Outlook and Share-Price Trends

1-Year Price Performance
Analyst Consensus
2.0
Sell Hold Strong Buy
Target Price $18 +113.8% Current $8
52-Week Price Range
$8
Low $2 High $17
vs. low +453.95% vs. high -50.15%

In the near term, medical utilization and contract terms are the variables that decide earnings. If the company fails to manage actual costs against funding, losses can widen even as the top line grows, making contract selectivity and cost control the first things to verify. Over the medium to long term, aging demographics and the shift toward value-based care can serve as structural growth drivers. That said, micro-cap traits — funding conditions, dilution risk, and changes in government payment methodology — remain sources of potential volatility.

🎯 Key Growth Drivers
Expansion of the managed-member base driven by an aging population
The institutional shift toward value-based care
Growth of the affiliated physician network and entry into new geographies

⚔️ P3 Health Partners Core Strengths and Risks

A physician-led network and a value-based-care model are strengths, while medical-cost volatility and limited financial capacity are the core risks.

💪 Core Strengths

Physician-Led Network
Affiliations with local primary-care physicians create dense patient touchpoints and ensure effective care coordination.
Alignment With Policy Direction
The business model is well aligned with the US healthcare policy direction of moving toward value-based care.
Recurring Membership-Based Revenue
The per-member fixed-payment structure provides good revenue visibility as long as contracts are retained.
Scalable Model
Growth is achieved by adding affiliated physicians and regions, allowing the top line to expand without large in-house facility investments.

⚠️ Core Risks

Medical-Cost Volatility
If actual utilization exceeds expectations, costs outpace funding and losses widen.
Limited Financial Capacity
As a micro-cap, funding pressure and share-dilution risk remain persistent.
Policy and Payment-Methodology Changes
Changes in government payment methodology or evaluation criteria directly affect profitability.
Intensifying Competition
Large insurers and managed-care players are entering the same space, sharpening contract competition.

🔄 P3 Health Partners Competitors and Related Stocks (Beneficiaries)

Among healthcare facilities peers of similar size for direct comparison are mobile-care services player DCGO, Latin American hospital network AUNA, and dental-care network PARK. Operationally linked names include senior-focused health insurer HUM, broad healthcare services company CI, and public-insurance-focused CNC — and the contract terms with these insurers have a direct impact on P3's earnings.

Competitors
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
DCGODCGODocGo Inc$0.37-4.6%$36.6M-0.3-92.44%-
AUNAAUNAAuna SA$5.17-1.3%$382.6M94.70.70.81%-
PARKPARKPark Dental Partners Inc$20.98+4.0%$99.8M-3.3--
Related stocks (beneficiaries)
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
HUMHumana Inc$400.02-0.8%$48.0B37.92.56.83%0.92%
CICigna Group$278.17+0.8%$73.5B11.51.715.49%2.23%
CNCCentene Corp$64.06-0.8%$31.6B-1.4-20.41%-

✅ Investor Checklist for P3 Health Partners

Key items to check when evaluating P3 Health Partners. Membership trends and medical-cost management results, along with cash position, are the short-term core variables, while improvements in contract structure and the pace of geographic expansion should also be monitored.

Checklist ItemWhat to VerifyCurrent Status
👥 Membership ScaleNumber of managed members and attritionExpansion trend
💵 Medical-Cost ManagementPerformance controlling actual care costs against fundingImprovement needs monitoring
🏦 Financial CapacityCash position and ability to raise additional fundingConservative-review phase

If medical utilization comes in above expectations, losses can widen even as the top line grows. Given the micro-cap profile, share-price swings tend to be large and dilution risk from funding remains in play, while changes in government payment methodology are also reflected directly in profitability.

This is a managed-care company riding the structural wave of value-based care, but profitability normalization is still in the verification stage. Confirming membership growth and cost control at the same time is key, and a small, diversified allocation with a longer observation horizon is recommended.

Briefs · earnings · signals, first Subscribe
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →